Harmony Biosciences Holdings, Inc. HRMY Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $868.45M+21.5% | $714.73M+22.8% | $582.02M+32.9% | $437.86M+43.4% | ||
| $198.34M+26.5% | $156.82M+29.3% | $121.24M+45.2% | $83.48M+50.4% | ||
| $670.11M+20.1% | $557.92M+21.1% | $460.79M+30.0% | $354.37M+41.8% | ||
| 77.2%-0.9pp | 78.1%-1.1pp | 79.2%-1.8pp | 80.9%-0.9pp | ||
| $189.59M+30.0% | $145.83M+91.7% | $76.06M+7.3% | $70.89M+133% | ||
| $119.51M+7.8% | $110.92M+13.9% | $97.4M+22.9% | $79.29M+16.4% | ||
| $152.54M+38.2% | $110.35M+15.8% | $95.29M+13.4% | $84.02M+31.5% | ||
| $461.64M+25.8% | $367.09M+36.6% | $268.76M+14.8% | $234.19M+44.2% | ||
| $208.47M+9.2% | $190.83M-0.6% | $192.03M+59.8% | $120.19M+37.3% | ||
| 24%-2.7pp | 26.7%-6.3pp | 33%+5.5pp | 27.4%-1.2pp | ||
| $14.65M-16.3% | $17.5M-26.4% | $23.76M+26.4% | $18.8M-22.3% | ||
| -$680K— | —— | $159K-5.9% | $169K+956% | ||
| $215.06M+12.1% | $191.8M+10.6% | $173.4M+65.6% | $104.69M+180% | ||
| $56.38M+21.7% | $46.31M+4.0% | $44.54M+158% | -$76.78M-2,812% | ||
| $158.69M+9.1% | $145.49M+12.9% | $128.85M-29.0% | $181.47M+425% | ||
| 18.3%-2.1pp | 20.4%-1.8pp | 22.1%-19.3pp | 41.4%+30.1pp | ||
| $2.72+8.4% | $2.51+18.4% | $2.12-28.6% | $2.97+412% | ||
| $232.33M+8.1% | $214.94M-0.7% | $216.39M+50.7% | $143.57M+35.0% | ||
| 26.8%-3.3pp | 30.1%-7.1pp | 37.2%+4.4pp | 32.8%-2.0pp | ||
| $208.47M+9.2% | $190.83M-0.6% | $192.03M+59.8% | $120.19M+37.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Harmony Biosciences Holdings, Inc.'s profit margins?
- Gross margin is 76.5% and operating margin is 21.1%, with a 16.2% net margin.
- Where does Harmony Biosciences Holdings, Inc.'s income statement data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.